|
Evaluating real-world overall survival (rwOS) across oncology data sources: Friends of Cancer Research non-small cell lung cancer pilot study. |
|
|
Employment - AgNovos (I); Qiagen (I); Regulatory and Quality Solutions (I); Smith & Nephew (I) |
|
|
Employment - Flatiron Health |
|
|
|
Stock and Other Ownership Interests - COTA |
|
|
Employment - Ontada/McKesson |
|
|
|
Stock and Other Ownership Interests - GlaxoSmithKline; IQVIA |
|
|
Employment - Flatiron Health |
Stock and Other Ownership Interests - Flatiron Health; Roche |
|
|
No Relationships to Disclose |
|
|
Consulting or Advisory Role - Deciphera; TYME |
|
|
Employment - COTA Healthcare |
Stock and Other Ownership Interests - Abbvie; COTA Healthcare; Johnson & Johnson; UnitedHealthcare |
|
|
|
Stock and Other Ownership Interests - Syapse |
Research Funding - Syapse |
|
|
Employment - ConcertAI; Syapse |
Stock and Other Ownership Interests - ConcertAI; Syapse |
Travel, Accommodations, Expenses - Syapse |
|
|
No Relationships to Disclose |
|
|
|
|
Stock and Other Ownership Interests - Johnson & Johnson (I); McKesson; Oncolytics (I) |
Honoraria - Bristol-Myers Squibb; Roche |
Consulting or Advisory Role - Advi; Boehringer Ingelheim; Bristol-Myers Squibb; New Century Health |
|
|
No Relationships to Disclose |
|
|
|
Stock and Other Ownership Interests - Syapse |
|
|
Employment - Flatiron Health |
Stock and Other Ownership Interests - Roche |
|
|
Employment - IQVIA; Merck (I) |
Stock and Other Ownership Interests - IQVIA; Merck (I) |
|
|
No Relationships to Disclose |